1 Patient inclusion in clinical trial design
- At what stage in the development process should patient perspectives be considered?
- What are the mutual benefits to both patients and industry to collaborate in trial design?
- What are current barriers industry faces in bringing greater patient involvement into trial design and how to remedy them?
- How to assure patients will feel valued as collaborators in trial development?
2 Patient inclusion in clinical trial design – why it matters for industry
The Pazienti e Industrie event in Milan brought together >40 participants from patient organizations, caregivers & industry representatives.
In the rapidly evolving healthcare industry, there is a noticeable and positive shift towards a patient-centered approach, with a strong emphasis on empathy. This newfound focus on empathy has proven to be crucial in the realm of clinical trials, particularly when it comes to participant recruitment and retention.
In this enlightening 5th episode of the Patients on the Move Podcast, host Roger Legtenberg sits down with Jaime Sanders, aka 'The Migraine Diva'. Join this impactful conversation as they delve into medical gaslighting, stigmas in migraine disorders, and potential counter strategies.
We invite patients with the diagnosis IgAN / FSGS as well as relatives & partners to a moderated exchange.
We are happy to be part of the initiative “Hepatitisfreies-Köln” (hepatitis-free Cologne)
In the dynamic world of clinical development, one fact is undeniable: the patient voice is critical.
admedicum is pleased to support World Pulmonary Hypertension Day and would like to share our new project role as Secretariat for the Alliance for Pulmonary Hypertension.
In this episode Bojana and Philipp discussed how patient advocacy & patient engagement can help prepare patient access.
Why we may develop "blind spots” when living with a chronic disease... Philipp von Gallwitz tells his personal story.
Tom and Andreas share their thoughts on the roles & best practices for patient involvement in HTA processes.